How many tablets of Bactrim (sulfamethoxazole/trimethoprim) should be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bactrim Dosing Recommendations

For adults with skin and soft tissue infections (SSTI), administer 1-2 double-strength tablets twice daily; for urinary tract infections, use 1 double-strength tablet twice daily; and for Pneumocystis jirovecii pneumonia (PCP) treatment, the dosing is weight-based at 75-100 mg/kg/day of sulfamethoxazole divided every 6 hours.

Dosing by Indication

Skin and Soft Tissue Infections (SSTI)

For MRSA or MSSA skin infections, the standard adult dose is 1-2 double-strength (DS) tablets (800/160 mg) twice daily 1. This regimen provides bactericidal coverage and is particularly useful when other first-line agents cannot be used, though efficacy data remains limited compared to agents like vancomycin or linezolid.

Pediatric dosing: 8-12 mg/kg/day based on the trimethoprim component, given in either 4 divided doses IV or 2 divided doses orally 1.

Urinary Tract Infections

Adults should receive 1 double-strength tablet twice daily for 3 days for acute uncomplicated cystitis 2. This shorter duration (3 days) has been validated in multiple trials showing equivalent efficacy to longer courses while reducing adverse events 2.

For complicated UTIs or pyelonephritis, extend treatment to 10-14 days with the same dosing 3.

Pediatric dosing: 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours in two divided doses 3.

Pneumocystis jirovecii Pneumonia (PCP)

Treatment dosing: 75-100 mg/kg/day sulfamethoxazole (15-20 mg/kg/day trimethoprim) divided every 6 hours for 14-21 days 3. For an 80 kg adult, this translates to 5 regular tablets or 2.5 double-strength tablets every 6 hours (upper limit dosing).

Prophylaxis dosing: 1 double-strength tablet daily 4, 3. Alternative regimens include twice-weekly dosing, though this is less well-established 5.

Pediatric treatment: Same weight-based dosing as adults (75-100 mg/kg/day sulfamethoxazole) 3.

Special Populations

Renal Impairment

Critical adjustment required:

  • CrCl >30 mL/min: Standard dosing
  • CrCl 15-30 mL/min: Reduce dose by 50%
  • CrCl <15 mL/min: Use not recommended 3

Other Indications

Shigellosis/Traveler's diarrhea: 1 DS tablet twice daily for 5 days 3

Acute exacerbations of chronic bronchitis: 1 DS tablet twice daily for 14 days 3

Important Caveats

Contraindications:

  • Pediatric patients <2 months of age 3
  • Pregnancy (especially first trimester and near term)
  • Severe renal impairment (CrCl <15 mL/min)

Adverse events to monitor:

  • Rash occurs 2.5-fold more frequently than with other antibiotics 6
  • Severe cutaneous reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) are significantly elevated compared to alternatives like azithromycin 6
  • Hematologic toxicity (pancytopenia, neutropenia, thrombocytopenia) 6
  • Electrolyte disturbances (hyperkalemia, hyponatremia) 6

Resistance considerations: In areas where E. coli resistance to TMP-SMX exceeds 20%, alternative agents should be strongly considered for empiric UTI treatment 2. Clinical cure rates drop significantly (84% vs 41%) when treating TMP-SMX-resistant organisms 2.

The dosing must be adjusted based on the specific infection being treated, with PCP requiring the highest doses and shortest-course UTI treatment requiring the lowest total drug exposure. Always verify renal function before initiating therapy and adjust accordingly.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.